Life Sciences Tools and Services
Company Overview of Galilaeus Oy
Galilaeus Oy was established in 1994 and it is a biotechnological company. The company carries out research and development of drugs using genetic engineering of Streptomyces secondary metabolism. The company excels in the field and offers services for bio-transformation of pharmaceutically active compounds, extracts from the Combinatorial Biosynthesis collection. The company’s headquarters is located in Kaarina, Finland. The target areas for therapeutic use are as follows: Combinatorial, biosynthesis, biotransformation, natural, extracts, compounds.
Founded in 1994
358 2 274 1450
358 2 273 1460
Key Executives for Galilaeus Oy
Similar Private Companies By Industry
|Aranda Pharma Oy||Europe|
|Clinical Research Services Turku CRST Oy||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Galilaeus Oy, please visit www.galilaeus.fi. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.